Post by Novartis Europe

3,943 followers

Behind every research decision, every clinical trial, and every regulatory process, there is a patient waiting. Europe has world-class science, exceptional talent, and a proud tradition of research excellence. But that potential only matters when innovation translates into real outcomes for patients. A strong life sciences industry, supported by a predictable regulatory environment, helps ensure that breakthroughs reach patients sooner, clinical trials continue to take place in Europe, and the region remains a place where innovation can be developed and delivered. šŸŽ„ Hear from our Novartis leaders on what life sciences means for patients across Europe. With Julie Chauvet (Head, EU Public Affairs), Aoiffe O'Brien (Executive Director, Policy and Portfolio Advocacy Europe), Hugh Pullen (Head, Europe Public Affairs) and Vincent Vanwijnsberghe (Director, EU Public Affairs). #NovartisEurope

Post content

Video Content